van Galen Peter, Viny Aaron D, Ram Oren, Ryan Russell J H, Cotton Matthew J, Donohue Laura, Sievers Cem, Drier Yotam, Liau Brian B, Gillespie Shawn M, Carroll Kaitlin M, Cross Michael B, Levine Ross L, Bernstein Bradley E
Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Cancer Research, Massachusetts General Hospital, Boston, MA 02114, USA.
Human Oncology and Pathogenesis Program and Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.
Mol Cell. 2016 Jan 7;61(1):170-80. doi: 10.1016/j.molcel.2015.11.003. Epub 2015 Dec 10.
Genome-wide profiling of histone modifications can provide systematic insight into the regulatory elements and programs engaged in a given cell type. However, conventional chromatin immunoprecipitation and sequencing (ChIP-seq) does not capture quantitative information on histone modification levels, requires large amounts of starting material, and involves tedious processing of each individual sample. Here, we address these limitations with a technology that leverages DNA barcoding to profile chromatin quantitatively and in multiplexed format. We concurrently map relative levels of multiple histone modifications across multiple samples, each comprising as few as a thousand cells. We demonstrate the technology by monitoring dynamic changes following inhibition of p300, EZH2, or KDM5, by linking altered epigenetic landscapes to chromatin regulator mutations, and by mapping active and repressive marks in purified human hematopoietic stem cells. Hence, this technology enables quantitative studies of chromatin state dynamics across rare cell types, genotypes, environmental conditions, and drug treatments.
全基因组组蛋白修饰谱分析能够为特定细胞类型中参与的调控元件和程序提供系统性的见解。然而,传统的染色质免疫沉淀及测序(ChIP-seq)无法获取组蛋白修饰水平的定量信息,需要大量起始材料,且涉及对每个单独样本的繁琐处理。在此,我们利用一种借助DNA条形码对染色质进行定量和多重分析的技术来解决这些局限性。我们同时绘制多个样本中多种组蛋白修饰的相对水平,每个样本包含少至一千个细胞。我们通过监测抑制p300、EZH2或KDM5后的动态变化、将改变的表观遗传景观与染色质调节因子突变相联系以及绘制纯化的人类造血干细胞中的活性和抑制性标记,来展示该技术。因此,这项技术能够对稀有细胞类型、基因型、环境条件和药物处理下的染色质状态动态进行定量研究。